IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase I drugs for Spinal Cord Disorders have an 86% phase transition ...
Increase in cannabis poisoning seen with medical cannabis laws and recreational cannabis laws. HealthDay News — Medical cannabis laws (MCLs) are associated with increased cannabis use disorder ...
New cognitive disorders were diagnosed in 1.5% of patients who did not take the test and 9% of those who did, a six fold increase. “This study proved it was feasible and it was well received in ...
No, seriously. Every year we cap off these awards by honoring an entity that’s helped make cord-cutting easier or better. In 2024, it’s hard to think of better recipients than the current FCC ...
Despite attempts to give off the impression of unity, the absence of key family members was difficult to ignore. European Editor at Large European Editor at Large [email protected] Got a ...